businessbriefs
10:15in productionCh. 1 · The Pitch/ 10:15 · ceiling 15 min
Scandals

Theranos

Elizabeth Holmes · 2003

A $9 billion valuation built on a device that didn’t work — and a revenue claim that was off by three orders of magnitude.

Theranos was a health technology company founded in 2003 in Palo Alto, California, that falsely claimed to perform rapid, accurate blood tests using minimal blood volume via proprietary devices; investigations revealed it relied on conventional machines, produced inaccurate results, voided two years of Edison data, and misrepresented its capabilities to investors, partners, and regulators.

ScandalsFraudScientific methodSilicon ValleyFraud across the network →
Chapters & takeaways5
  1. 0:46
    The Pitch

    Theranos was founded in 2003 by Elizabeth Holmes, who pitched a radical reimagining of blood testing using fingerprick samples.

  2. 2:10
    The Device That Wasn’t Used

    Theranos claimed to run tests on its proprietary Edison device — but used third-party machines for most testing.

  3. 4:05
    The Data That Was Erased

    The Edison device produced inaccurate results — so Theranos voided two years of its own data.

  4. 5:33
    The Funding Built on Lies

    Theranos raised $700 million by lying — about accuracy, military use, and revenue.

  5. 6:44
    The Breakthrough That Wasn’t

    Theranos was publicly presented as a breakthrough — but its breakthrough existed only in press releases and boardrooms.

Worth your time?

Yes. Study the whole thing.

1.5/ 5
What works
  • marketing
  • fundraising
  • legal intimidation
What does not
  • works
  • delivers
  • validates
  • scales
Study it if
  • investors
  • regulators
  • patients
Skip it if
  • clinicians
  • scientists
  • consumers
The written brief1 min read

What the company or idea is

Theranos was a health technology company founded in 2003 in Palo Alto, California, that falsely claimed to perform rapid, accurate blood tests using minimal blood volume via proprietary devices.

How it actually makes money

Theranos made no meaningful revenue: it claimed a $100-million revenue stream in 2014 but actually made only $100,000.

What works

Nothing worked at scale. Its core device failed. Its clinical validation failed. Its commercial partnerships collapsed when tested. Its financial claims were fabricated.

What does not

Its Edison device did not work. It gave inaccurate results. Theranos voided two years of its data. It did not use its own devices for most tests — it relied on commercially available machines from other manufacturers.

What to take from it

A company’s valuation is not evidence of technical validity. When the gap between marketing claims and operational reality is wide — and enforced by secrecy and litigation — the business model is fraud, not innovation.

Is it worth your time

Yes — as a case study in how false claims about technical capability, when backed by aggressive legal intimidation and media manipulation, can attract $700 million in investment without delivering a functional product.

Same desk · Scandals4 of 22
11:27
GSK plcHenry Wellcome · 2000GSK plc is a British multinational pharmaceutical and biotechnology company formed in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham. It traces its origins to Henry Wellcome’s 1880 co-founding of Burroughs Wellcome & Company. GSK developed the first malaria vaccine (RTS,S), markets WHO-listed essential medicines, and reported $42.4 billion in revenue and $9.32 billion in earnings in 2025. In 2012, it pleaded guilty in the US to unlawful drug promotion, failure to report safety data, and physician kickbacks — agreeing to a $3 billion settlement, the largest healthcare fraud case in US history and the largest in the pharmaceutical industry. The Wellcome Foundation Ltd., established by Henry Wellcome in 1924, was later sold to GSK following changes in UK charity law.
10:09
Wirecard scandal2020Wirecard collapsed on 25 June 2020 when €1.9 billion vanished — not due to market forces, but because its financial statements were systematically falsified. Forged contracts, round-tripping, and inflated 'adjusted' accounts masked zero real cash flow. Auditors signed off. Regulators deferred. Investors relied on metrics that bore no relation to IFRS standards. The scandal exposed a governance vacuum where complexity was weaponised to evade scrutiny.
9:47
WorldCom scandalWorldCom was a telecommunications company whose collapse resulted from systematic, top-down accounting fraud — 49 identical, undocumented journal entries that shifted $3.8 billion in operating expenses to the balance sheet as capital expenditures. This inflated assets by over $11 billion and turned a $395 million loss into a $130 million profit for Q1 2002. The fraud was uncovered by Cynthia Cooper’s internal audit unit — not external auditors or regulators. It exposed how financial reporting can be weaponised when controls are overridden and documentation abandoned.
9:40
Robert MaxwellRobert Maxwell built Pergamon Press by acquiring Butterworth-Springer in 1951 and rebranding it. He inflated its share price using transactions between his private family companies. In 1969, he lost control and was expelled from its board. A government inquiry concluded he could not be relied upon to steward a publicly quoted company. In 1984, he acquired Mirror Group Newspapers for £113 million. His death triggered immediate loan calls and the collapse of his empire. Posthumously, his fraudulent misappropriation of the Mirror Group pension fund was revealed.
Up next in Business

Thomas J. Watson Jr.

· 10:12

One Air Force contract built IBM’s electronics empire — not foresight, not genius, but scale-through-government.

Play nextBack to Scandals
10:12